VHC - Virus Hépatologie Cancer | HENRI MONDOR

Soutenir la recherche

Publications and Resources

Sort by :
Display :
21-30 sur 397

Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)

N Lydie, L Saboni, E Gautier, C Brouard, Stephane CHEVALIEZ, F Barin, C Larsen, F Lot, D Rahib,

JMIR Res Protoc. 12/10/2018;7(10) : e180 10.2196/resprot.9797.

PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.

J Yang, E Trepo, P Nahon, Q Cao, C Moreno, E Letouze, S Imbeaud, T Gustot, J Deviere, S Debette, P Amouyel, P Bioulac-Sage, Julien CALDERARO, N Ganne-Carrie, A Laurent, JF Blanc, E Guyot, A Sutton, M Ziol, J Zucman-Rossi, JC Nault,

Int J Cancer. 05/10/2018;- : - 10.1002/ijc.31910

French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes

P Cacoub, M Bourliere, T Asselah, V De Ledinghen, P Mathurin, Christophe HEZODE, L Henry, M Stepanova, ZM Younossi,

Value Health 01/10/2018;21(10) : 1218-1225 10.1016/j.jval.2018.01.006. 21/02/2018

Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.

C Lim, A Doussot, M Osseis, F Esposito, C Salloum, Julien CALDERARO, C Tournigand, D Azoulay,

Clin Trans Oncol. 01/10/2018;20(10) : 1274-1279 10.1007/s12094-018-1858-8 28/03/2018

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

P Houssel-Debry, A Coilly, C Fougerou-Leurent, C Jezequel, C Duvoux, V De Ledinghen, S Radenne, N Kamar, V Leroy, V Di Martino, L D'Alteroche, V Canva, F Conti, J Dumortier, H Montialoux, P Lebray, D Botta-Fridlund, A Tran, C Moreno, C Silvain, C Besch, P Perre, C Francoz, A Abergel, F Habersetzer, M Debette-Gratien, C Cagnot, A Diallo, Stephane CHEVALIEZ, E Rossignol, A Veislinger, JC Duclos-Vallee, GP Pageaux, ANRS CO23 CUPILT study group.

Hepatology 01/10/2018;68(4) : 1277-1287 10.1002/hep.29918

Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.

E Reizine, Giuliana AMADDEO, F Pigneur, L Baranes, F Legou, S Mule, B Zegai, V Roche, A Laurent, A Rahmouni, Julien CALDERARO, Alain LUCIANI,

Eur Radiol. 01/10/2018;28(10) : 4243-4253 10.1007/s00330-018-5438-7 02/05/2018

A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI.

N Louarn, L Aupin, N Benoist, M Desroches, Alain LUCIANI, D Bresson, J Hodel, E Itti,

Eur J Nucl Med Mol Imaging. 01/10/2018;45(11) : 2025 10.1007/s00259-018-4055-7. 24/05/2018

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

M van Tilborg, SH Al Marzooqi, WWL Wong, R Maan, J Vermehren, B Maasoumy, T Mazzulli, S Bolotin, G Garber, F Guerra, CR Flud, M Kowgier, HL Janssen, RJ de Knegt, Jean-Michel PAWLOTSKY, GA Cloherty, A Duarte-Rojo, C Sarrazin, H Wedemeyer, JJ Feld,

Lancet Gastroenterol Hepatol. 28/09/2018;pii: S2468-1253(18)30271-1 : 30271-1 10.1016/S2468-1253(18)30271-1.

High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon.

S Groc, JL Abbate, Frédéric LE GAL, Athenaïs GERBER, E Tuaillon, JL Albert, D Nkoghe, EM Leroy, B Roche, P Becquart,

J Viral Hepat. 23/09/2018;- : - 10.1111/jvh.12991.

Display :
21-30 sur 397